Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
Holding NMRA?
Track your performance easily

Neumora Therapeutics, Inc. (NMRA) Stock Investors

137 Followers
Based on 766,394 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NMRA
On average, investors allocate 0.00% of their portfolios to NMRA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 766,394 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NMRA

0.2%
Last 7
Days
18.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NMRA, out of 766,394 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NMRA Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,654 investors who made their portfolios public
The table shows changes in NMRA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NMRA Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
4.94%
+0.51%
+5.42%
7.63B
Healthcare
Vistra Energy
4.88%
+2.55%
+18.13%
48.75B
Utilities
Abbott Laboratories
3.55%
+0.53%
+14.08%
202.22B
Healthcare
Baidu
5.83%
+0.53%
+6.92%
32.09B
Communication Services
Chord Energy
4.20%
+1.45%
-1.18%
8.07B
Energy
DraftKings
5.42%
+0.81%
+0.53%
35.26B
Consumer Cyclical
Citigroup
4.76%
+0.63%
+3.70%
129.80B
Financial
Bristol-Myers Squibb
3.47%
-0.77%
-2.58%
109.81B
Healthcare
Caterpillar
4.43%
+0.08%
+0.78%
189.92B
Industrials
Marvell
5.29%
-1.35%
-2.32%
81.25B
Technology
Based on the activity of 766,394 active portfolios
Open your Smart Portfolio

NMRA Investor Analysis

NMRA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
0.0%
of NMRA holders
are under 35
Average Segment Performance
Average P/E Ratio26.57
Beta9.43
Dividend Yield51.54%
NMRA investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
50.0%
of NMRA holders
are between 35–55
Average Segment Performance
Average P/E Ratio24.84
Beta18.28
Dividend Yield25.17%
NMRA investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
50.0%
of NMRA holders
are over 55
Average Segment Performance
Average P/E Ratio23.97
Beta8.44
Dividend Yield41.02%
Overview of age group and performance of NMRA stock investors
See who invests in NMRA according to age group and performance.

FAQ

How many retail Investors hold NMRA?
<0.1% of TipRanks' retail investors hold NMRA in their portfolios.
    What is NMRA Investor Sentiment?
    NMRA’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of NMRA in the last 7 days?
      ▲ 0.2% of TipRanks' retail investors changed their holding of NMRA in the last 7 days.
        What percentage of retail investors changed their holding of NMRA in the last 30 days?
        ▲ 18.4% of TipRanks' retail investors changed their holding of NMRA in the last 30 days.
          What is the average age of retail investors who hold NMRA?
          The average age of NMRA Holders is over 55.
            What other stocks have NMRA investors also bought?
            NMRA Investors also bought VKTX, VST, ABT, BIDU, CHRD, DKNG, C, BMY, CAT, MRVL.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              CNCCentene
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis